54pc of sleep apnea suspects suffer from diabetes, high blood pressure: Study
Sleep apnea disrupts
the sleep cycle and can
dramatically impact energy, mental performance, and long term health
STAFF REPORTER
Around 54 per cent of obstructive sleep apnea (OSA) suspects suffer from either diabetes or high blood pressure and this is significantly higher when compared with the non-suspects group where the prevalence was only 21 per cent, revealed a study conducted by Philips Respironics in 10 countries on patient population in 2015-16 in observance of the World Sleep Day on last Friday.
The study further showcased only 17 per cent of the suspects consistently slept through the night, 14 per cent of suspects suffer from cardiac problem against only 6 per cent in the non-suspects group. 84 per cent of the suspects also confessed to people getting troubled because of their heavy snoring.
Globally, it is estimated that 100 million people suffer from OSA, with an overwhelming 80% of them remaining undiagnosed. The online risk assessment tool is designed to recommend those at high risk for OSA follow up with their healthcare provider.
Philips has made a significant effort to encourage people to be screened for OSA and other sleep disorders. Philips offers a host of resources to patients on its site www.sleepapnea.com showing a continued dedication to improving the lives of patients suffering from OSA or other serious sleep disorders.
Along with its online resource, Philips encourages people with poor sleep habits to take an online risk assessment test to determine their risk level for obstructive sleep apnea (OSA).
Sleep apnea is a common sleep disorder characterized by repeated interruptions in breathing throughout the sleep cycle.
These interruptions, called apneas, are caused by the collapse of soft tissue in the airway, which prevents oxygen from reaching the lungs. Weak muscles in the airway, a large tongue, obesity, and other factors may cause airway tissue to collapse and obstruct breathing.
Sleep apnea disrupts the sleep cycle and can dramatically impact energy, mental performance, and long term health. In some cases, if left untreated, sleep apnea can be fatal.
Philips commitment to sleep therapy started in 1985 with the first commercial Continuous Positive Airway Pressure (CPAP) machine. Now, the company offers a suite of simple to advanced fixed CPAP, auto-CPAP, and bi-level therapy systems that help to improve comfort and compliance for sleep-disordered breathing patients.
